Policy | September 26, 2023
India to launch National Policy on Research and Development and Innovation in Pharma-MedTech
Also to be launched Scheme for promotion of Research and Innovation in Pharma MedTech Sector (PRIP)
Also to be launched Scheme for promotion of Research and Innovation in Pharma MedTech Sector (PRIP)
To enable company to be future-ready by tapping potential in CDMO space
New digital platform provides global sponsors with live visibility into R&D, process development and GMP manufacturing operations, enhancing collaboration and decision-making
Pharma powerhouse names Cecile Guegan interim finance chief
The collaboration is focused on overcoming a major limitation in existing cancer drugs
Seasoned pharmaceutical R&D leader takes on an expanded leadership role to drive innovation and strengthen Hetero’s advanced formulation development capabilities
Knowledge paper highlights biosimilars, biologics, AI-driven drug discovery and regulatory excellence as key growth drivers for the next phase of India's pharma expansion
The collaboration aims to develop differentiated biologics that offer greater convenience and accessibility for patients
Pharmaceutical R&D veteran brings over 20 years of expertise in formulation development, ANDA filings, and regulated-market product innovation to strengthen MSN Laboratories’ global growth ambitions
The validation confirms the submission is complete, clearing the way for the EMA’s centralized review process to formally evaluate the therapy
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
